Biota Accelerates Anti-infective Portfolio
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 11 (Table of Contents)
Published: 19 Nov-2009
DOI: 10.3833/pdr.v2009.i11.1275 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Biota Holdings, a major Australian antiviral drug developer, has acquired two companies to add antibacterial assets to existing pipeline which is focused on antivirals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS